For Health Care Professionals


Find Physician
Enter Zip Code
Full Prescribing Information
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Find Advocacy Groups

This section lists US-based prostate cancer advocacy, education, and support organizations.

This information is offered as a resource to prostate cancer patients and caregivers. The organizations listed are not necessarily endorsed by Ferring Pharmaceuticals Inc.

American Urological Association Foundation
1-800-828-7866

The AUA Foundation, the world's leading nonprofit urologic health organization, promotes research, education, and advocacy. The foundation’s mission is to promote help, provide hope, and promise a future free of urologic disease.

Malecare Prostate Cancer Support

Malecare is the largest all-volunteer, nonprofit organization in the United States for men diagnosed with cancer.

Men’s Health Network
202-543-MHN-1 (202-543-6461)

Men's Health Network (MHN) is a national nonprofit organization whose mission is to reach men and their families where they live, work, play, and pray with health prevention messages and tools, screening programs, educational materials, advocacy opportunities, and patient navigation.

National Alliance of State Prostate Cancer Coalitions
1-877-NASPCC8 (1-877-627-7228)

The National Alliance of State Prostate Cancer Coalitions (NASPCC) provides support to existing state prostate cancer organizations, facilitates the development of new state prostate cancer organizations, and serves as a collective and collaborative voice to make prostate cancer a national health care priority.

Prostate Cancer Foundation
1-800-757-CURE (1-800-757-2873)

The Prostate Cancer Foundation, an organization founded to find better treatments and a cure for recurrent prostate cancer, is the largest private source for research funding for prostate cancer. The foundation has funded more than 1,500 programs at nearly 200 research centers in 20 countries around the world.

Prostate Conditions Education Council
1-866-477-6788

The Prostate Conditions Education Council is dedicated to saving lives through awareness and the education of men, their partners, and the medical community about the prevalence of prostate cancer, the importance of early detection, available treatment options, and other men's health issues.

Prostate Health Education Network
781-487-2239

The Prostate Health Education Network’s (PHEN) primary mission is to increase prostate health education and awareness among the men in the United States at highest risk for prostate cancer: African Americans. Saving lives through early detection and eliminating the African American prostate cancer disparity are PHEN's education and awareness goals.

The National Men’s Resource Center (Prostate Cancer Awareness Week)
415-241-6868

Prostate Cancer Awareness Week is initiated by the National Men's Resource Center to inform and educate men on the many issues that confront them today regarding the possible dangers of prostate cancer.

The Prostate Net
1-888-477-6763

The Prostate Net is engaged in empowering consumers, patients, survivors, and their families and caregivers through education and information to make the appropriate decisions about treating prostate diseases and ensuring the desired quality of life.

Us TOO International
1-800-80-Us TOO (1-800-808-7866)

Us TOO is dedicated to communicating timely and reliable information enabling informed choices regarding detection and treatment of prostate cancer. The organization offers fellowship, shared counseling, and discussion sessions in both formal and informal settings.

Women Against Prostate Cancer
202-580-5730

Women Against Prostate Cancer (WAPC) is a national organization working to unite the voices and provide support for the millions of women and their families affected by prostate cancer. WAPC advocates prostate cancer education, public awareness, screenings, legislation, and treatment options.

ZERO – The Project to End Prostate Cancer
1-888-245-9455

ZERO – the Project to End Prostate Cancer works to reduce the burden of prostate cancer on American men and their families through awareness, outreach, and advocacy. ZERO provides comprehensive treatment information to patients, educates those at risk, conducts free screenings, increases research funds from the federal government to find new treatments, and funds research in the pursuit of a better test for the disease.

WHAT IS FIRMAGON?

FIRMAGON® is a prescription medicine used in the treatment of advanced prostate cancer.

IMPORTANT SAFETY INFORMATION

FIRMAGON® should not be given to people who are allergic to any of the ingredients in FIRMAGON®. It should not be given to women who are pregnant or may become pregnant. FIRMAGON® can harm an unborn baby when given to a pregnant woman.

Before receiving FIRMAGON®, tell your healthcare provider about all your medical conditions, including if you have any heart problems, problems with balance of your body salts or electrolytes (such as, sodium, potassium, calcium, and magnesium), or have kidney or liver problems.

The common side effects of FIRMAGON® include: hot flashes, injection site pain, redness and swelling (especially with the first dose), weight gain, increase in some liver enzymes, tiredness, hypertension, back and joint pain, chills, urinary tract infection, and decrease sex drive and trouble with erectile function (impotence).

Please see the Full Prescribing Information. You can view or download it by clicking on the link in the right-hand column of the page.

The information on this Web site is provided for educational purposes only. While there may be information on this Web site related to certain medical conditions and their treatment, should a medical condition exist, promptly see your own physician or health care provider as the information on this Web site is not intended to take the place of advice from a physician or health care professional. Ferring does not offer personalized medical diagnosis or patient-specific treatment advice. The statements made by doctors on this Web site represent their own individual experiences and opinions and is not intended to be medical advice. Indeed, only your doctor or other health care professional, as a learned intermediary, can determine if a product described in this Web site is appropriate for you.

This Web site is intended for US residents only.

* With continued use, FIRMAGON has been shown to maintain testosterone at medically acceptable levels for up to 1 year.1
** In secondary endpoints of a 1-year, pivotal, phase 3 noninferiority-designed study; FIRMAGON: n=207; leuprolide: n=201.1

References:
1. Klotz L, Boccon-Gibod L, Shore ND, et al. The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer. BJU Int. 2008;102(11):1531-1538. 2. Van Poppel H, Nilsson S. Testosterone surge: rationale for gonadotropin-releasing hormone blockers? Urology. 2008;71(6):1001-1006. 3. Lupron Depot® [package insert]. North Chicago, IL: Abbott Laboratories; 2008. 4. Weckermann D, Harzmann R. Hormone therapy in prostate cancer: LHRH antagonists versus LHRH analogues. Eur Urol. 2004;46(3):279-284.